Literature DB >> 11700062

Crystal structure of the dimeric phosphoenolpyruvate carboxykinase (PEPCK) from Trypanosoma cruzi at 2 A resolution.

S Trapani1, J Linss, S Goldenberg, H Fischer, A F Craievich, G Oliva.   

Abstract

ATP-dependent phosphoenolpyruvate carboxykinase (PEPCK) (ATP: oxaloacetate carboxylyase (transphosphorylating), EC 4.1.1.49) is a key enzyme involved in the catabolism of glucose and amino acids in the parasite Trypanosoma cruzi, the causative agent of Chagas' disease. Due to the significant differences in the amino acid sequence and substrate specificity of the human enzyme (PEPCK (GTP-dependent), EC 4.1.1.32), the parasite enzyme has been considered a good target for the development of new anti-chagasic drugs. We have solved the crystal structure of the recombinant PEPCK of T. cruzi up to 2.0 A resolution, characterised the dimeric organisation of the enzyme by solution small angle X-ray scattering (SAXS) and compared the enzyme structure with the known crystal structure of the monomeric PEPCK from Escherichia coli. The dimeric structure possesses 2-fold symmetry, with each monomer sharing a high degree of structural similarity with the monomeric structure of the E. coli PEPCK. Each monomer folds into two complex mixed alpha/beta domains, with the active site located in a deep cleft between the domains. The two active sites in the dimer are far apart from each other, in an arrangement that seems to permit an independent access of the substrates to the two active sites. All residues of the E. coli PEPCK structure that had been found to interact with substrates and metal cofactors have been found conserved and in a substantially equivalent spatial disposition in the T. cruzi PEPCK structure. No substrate or metal ion was present in the crystal structure. A sulphate ion from the crystallisation medium has been found bound to the active site. Solution SAXS data suggest that, in solutions with lower sulphate concentration than that used for the crystallisation experiments, the actual enzyme conformation may be slightly different from its conformation in the crystal structure. This could be due to a conformational transition upon sulphate binding, similar to the ATP-induced transition observed in the E. coli PEPCK, or to crystal packing effects. The present structure of the T. cruzi PEPCK will provide a good basis for the modelling of new anti-chagasic drug leads. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11700062     DOI: 10.1006/jmbi.2001.5093

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  10 in total

Review 1.  Biochemistry and evolution of anaerobic energy metabolism in eukaryotes.

Authors:  Miklós Müller; Marek Mentel; Jaap J van Hellemond; Katrin Henze; Christian Woehle; Sven B Gould; Re-Young Yu; Mark van der Giezen; Aloysius G M Tielens; William F Martin
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

Review 2.  Structural insights into the mechanism of phosphoenolpyruvate carboxykinase catalysis.

Authors:  Gerald M Carlson; Todd Holyoak
Journal:  J Biol Chem       Date:  2009-07-27       Impact factor: 5.157

3.  Saccharomyces cerevisiae phosphoenolpyruvate carboxykinase: the relevance of Glu299 and Leu460 for nucleotide binding.

Authors:  Estela Pérez; Emilio Cardemil
Journal:  Protein J       Date:  2010-07       Impact factor: 2.371

4.  Relevance of phenylalanine 216 in the affinity of Saccharomyces cerevisiae phosphoenolpyruvate carboxykinase for Mn(II).

Authors:  Alejandro Yévenes; Fernando D González-Nilo; Emilio Cardemil
Journal:  Protein J       Date:  2007-02       Impact factor: 2.371

5.  Structural comparisons of phosphoenolpyruvate carboxykinases reveal the evolutionary trajectories of these phosphodiester energy conversion enzymes.

Authors:  Yoko Chiba; Takuya Miyakawa; Yasuhiro Shimane; Ken Takai; Masaru Tanokura; Tomoyoshi Nozaki
Journal:  J Biol Chem       Date:  2019-10-28       Impact factor: 5.157

6.  Molecular and biochemical characterization of phosphoenolpyruvate carboxykinase in the ruminal bacterium Ruminococcus albus.

Authors:  Narito Asanuma; Kimio Yoshizawa; Kazuhiro Kanada; Tsuneo Hino
Journal:  Curr Microbiol       Date:  2009-02-05       Impact factor: 2.188

7.  Structural and functional studies of phosphoenolpyruvate carboxykinase from Mycobacterium tuberculosis.

Authors:  Iva Machová; Jan Snášel; Jiří Dostál; Jiří Brynda; Jindřich Fanfrlík; Mahavir Singh; Ján Tarábek; Ondřej Vaněk; Lucie Bednárová; Iva Pichová
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

Review 8.  The Potential of Secondary Metabolites from Plants as Drugs or Leads against Protozoan Neglected Diseases-Part III: In-Silico Molecular Docking Investigations.

Authors:  Ifedayo Victor Ogungbe; William N Setzer
Journal:  Molecules       Date:  2016-10-19       Impact factor: 4.411

9.  Phylogenetic study of the evolution of PEP-carboxykinase.

Authors:  Sanjukta Aich; Louis T J Delbaere
Journal:  Evol Bioinform Online       Date:  2007-12-11       Impact factor: 1.625

10.  The Trypanosome UDP-Glucose Pyrophosphorylase Is Imported by Piggybacking into Glycosomes, Where Unconventional Sugar Nucleotide Synthesis Takes Place.

Authors:  Oriana Villafraz; Hélène Baudouin; Muriel Mazet; Hanna Kulyk; Jean-William Dupuy; Erika Pineda; Cyrille Botté; Daniel Ken Inaoka; Jean-Charles Portais; Frédéric Bringaud
Journal:  mBio       Date:  2021-05-28       Impact factor: 7.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.